[HTML][HTML] Unraveling hematopoiesis through the lens of genomics

LA Liggett, VG Sankaran - Cell, 2020 - cell.com
Hematopoiesis has long served as a paradigm of stem cell biology and tissue homeostasis.
In the past decade, the genomics revolution has ushered in powerful new methods for …

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases

K Hemminki, A Försti, R Houlston… - International journal of …, 2021 - Wiley Online Library
Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …

Deciphering the genetics and mechanisms of predisposition to multiple myeloma

M Went, L Duran-Lozano, GH Halldorsson… - Nature …, 2024 - nature.com
Multiple myeloma (MM) is an incurable malignancy of plasma cells. Epidemiological studies
indicate a substantial heritable component, but the underlying mechanisms remain unclear …

Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk

A Sud, S Chattopadhyay, H Thomsen… - Blood, The Journal …, 2019 - ashpublications.org
Estimating familial cancer risks is clinically important in being able to discriminate between
individuals in the population at differing risk for malignancy. To gain insight into the familial …

[HTML][HTML] Artificial intelligence predicted overall survival and classified mature B-cell neoplasms based on immuno-oncology and immune checkpoint panels

J Carreras, G Roncador, R Hamoudi - Cancers, 2022 - mdpi.com
Simple Summary Artificial intelligence (AI) is a field that combines computer science with
robust datasets to solve problems. AI in medicine uses machine learning and deep learning …

Integrative characterization of G-Quadruplexes in the three-dimensional chromatin structure

Y Hou, F Li, R Zhang, S Li, H Liu, ZS Qin, X Sun - Epigenetics, 2019 - Taylor & Francis
ABSTRACT DNA molecules are highly compacted in the eukaryotic nucleus where distal
regulatory elements reach their targets through three-dimensional chromosomal …

Genome instability in multiple myeloma: Facts and factors

AY Aksenova, AS Zhuk, AG Lada, IV Zotova… - Cancers, 2021 - mdpi.com
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …

The impact of tumor heterogeneity on diagnostics and novel therapeutic strategies in multiple myeloma

L Rasche, KM Kortüm, MS Raab… - International journal of …, 2019 - mdpi.com
Myeloma is characterized by extensive inter-patient genomic heterogeneity due to multiple
different initiating events. A recent multi-region sequencing study demonstrated spatial …

Next-generation sequencing for clinical management of multiple myeloma: ready for prime time?

N Bolli, E Genuardi, B Ziccheddu, M Martello… - Frontiers in …, 2020 - frontiersin.org
Personalized treatment is an attractive strategy that promises increased efficacy with
reduced side effects in cancer. The feasibility of such an approach has been greatly boosted …

Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma

D Kegyes, D Gulei, R Drula, D Cenariu, B Tigu, D Dima… - Blood Reviews, 2023 - Elsevier
Multiple myeloma (MM) is a malignant plasma cell disorder accounting for around 1.8% of
all neoplastic diseases. Nowadays, clinicians have a broad arsenal of drugs at their disposal …